CMPX vs MU · $367.4M cap vs P/E 21, rev $37.38B
Compass Therapeutics Inc. (CMPX) versus Micron Technology Inc (MU) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Micron Technology Inc (MU) is a semiconductors company listed on US. It is led by Sanjay Mehrotra.
CMPX does not have a complete income-statement cache yet.
Latest reported MU revenue for 2025-08-28 was $37.38B. Net income was $8.54B. MU currently screens at market cap $187.25B and trailing P/E 20.7.
CMPX currently screens at market cap $367.4M. MU currently screens at market cap $187.25B and trailing P/E 20.7.
Not investment advice. Open the CMPX and MU stock pages for the full models.
Not investment advice.